A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome

Clinical trial NCT07406932 · RECRUITING

Trial details

NCT number: NCT07406932
Sponsor: China-Japan Friendship Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Antisynthetase Syndrome Interstitial Lung Disease (ILD)

Start date: 2026-05-18
Primary completion: 2027-07-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.